Niche pharmaceuticals

Yes. After the drug goes off patent the price is expected to drop and the profit margin drips by 80 percent easily.

The US spends twice per capita of Europe on health yet has a lower life expectancy. I have not seen any good explanation for this but the short of it is that the US citizens get a rough deal here.

There have been mass firings recently. One company fired 2000 researchers. expect salary levels to increase as pharmaceutical research looks less inviting as a career. This will mean a 20 year period of little progress in drugs development,

Companies want to cover r&d costs, however they are greedy so they do it so they cover r&d costs, then get a profit of how much it costs to make it, then times that by 5000 to get price

>One company fired 2000 researchers.

Which was this? Any particular field? And was it a true firing or a conversion into fixed term contracts.

You know the system is fucked when the cost of regular drugs is soaring for no good reason.

> soaring for no good reason
> not because they can corner the market because everyone else is a fucking retard who can't follow a patent

also
> epipens
> regular drugs

"being legally allowed to" is not a good reason to raise a drug's price

human health should never have been made a free market

But mostly because the government will hold up any competitors medication from passing FDA trials for decades, for an ample fee.